Common names: Cascara sagrada, Sacred bark
Botanical names: Cascara sagrada, Rhamnus
purshiani cortex
© Steven Foster
Parts used and where grown
Cascara is a small to medium-size tree native to the provinces and states of the Pacific
coast, including British Columbia, Washington, Oregon, and northern California. The bark of
the tree is removed, cut into small pieces, and dried for one year before being used
medicinally. Fresh cascara bark has an emetic or vomit-inducing property and therefore is not
used.
Cascara has been used in
connection with the following conditions (refer to the individual
health concern for complete information):
Historical or traditional use (may
or may not be supported by scientific studies)
Northern California Indians introduced this herb, which they called sacred bark, to 16th
century Spanish explorers. As it is much milder in its laxative action than the herb
buckthorn, cascara became popular in Europe as a treatment for constipation. Cascara has been an approved treatment
for constipation in the U.S. Pharmacopoeia since 1890.1
Active constituents
Cascara bark is high in hydroxyanthraquinone glycosides called cascarosides. Resins,
tannins, and lipids make up the bulk of the other bark ingredients. Cascarosides have a
cathartic action that induces the large intestine to increase its muscular contraction
(peristalsis), resulting in bowel movement.2
How much is usually taken?
Only the dried form of cascara should be used. Capsules providing 20–30 mg of
cascarosides per day can be used. However, the smallest amount necessary to maintain soft
stool should be used.3 As a tincture, 1/4–1 teaspoon (1–5 ml) per day
is generally taken. It is important to drink eight 6-ounce (180 ml) glasses of water
throughout the day while using cascara. Cascara should be taken consecutively for no longer
than eight to ten days.4
Are there any side effects or interactions?
Women who are pregnant or breast-feeding,
and children under the age of 12 should not use cascara without the advice of a physician.
People with an intestinal obstruction,
Crohn’s disease, appendicitis or abdominal pain should not employ this
herb.5 Long-term use or abuse of cascara may result in weakened bowel function. It
may also cause a loss of electrolytes (especially the mineral potassium). Loss of potassium can lead to
abnormalities of heart function and may augment the action of digitalis-like medications with
fatal consequences.
Are there any drug
interactions?
Certain medicines may interact with cascara. Refer to drug interactions for a list of those medicines.
References
(To view, roll mouse over heading; to hide, click on heading)
1. Castleman M. The Healing Herbs. Emmaus, PA: Rodale Press,
1991, 99–100.
2. Leung AY, Foster S. Encyclopedia of Common Natural Ingredients
Used in Food, Drugs, and Cosmetics, 2d ed. New York: John Wiley & Sons, 1996,
128–30.
3. Blumenthal M, Busse WR, Goldberg A, et al. (eds). The Complete
Commission E Monographs: Therapeutic Guide to Herbal Medicines. Boston, MA: Integrative
Medicine Communications, 1998, 104–5.
4. Bradley PR, ed. British Herbal Compendium, vol 1.
Bournemouth, Dorset, UK: British Herbal Medicine Association, 1992, 52–4.
5. Blumenthal M, Busse WR, Goldberg A, et al. (eds). The Complete
Commission E Monographs: Therapeutic Guide to Herbal Medicines. Boston, MA: Integrative
Medicine Communications, 1998, 104–5.
Copyright © 2006 Healthnotes, Inc. All rights reserved.
www.healthnotes.com
Learn more about Healthnotes, the
company.
Learn more about the authors of
Healthnotes.
The information presented in Healthnotes is for informational purposes
only. It is based on scientific studies (human, animal, or in vitro), clinical
experience, or traditional usage as cited in each article. The results reported may not
necessarily occur in all individuals. For many of the conditions discussed, treatment with
prescription or over the counter medication is also available. Consult your doctor,
practitioner, and/or chemist for any health problem and before using any supplements or before
making any changes in prescribed medications. Information expires March 2007.